Ionis Pharmaceuticals IONS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's shares (diluted)?
- Ionis Pharmaceuticals (IONS) reported shares (diluted) of 164.9M in Q1 2026.
- How has Ionis Pharmaceuticals's shares (diluted) changed year-over-year?
- Ionis Pharmaceuticals's shares (diluted) increased by 3.9% year-over-year, from 158.7M to 164.9M.
- What is the long-term trend for Ionis Pharmaceuticals's shares (diluted)?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's shares (diluted) has grown at a 3.2% compound annual growth rate (CAGR), from 583.2M to 660.8M.
- What does shares (diluted) mean?
- The total number of shares that would exist if all potential stock options and convertible securities were converted.
- How do you interpret shares (diluted)?
- An increase indicates potential dilution for existing shareholders, often due to employee compensation or debt conversion.
- How does shares (diluted) compare across companies?
- Used to calculate diluted EPS; varies based on company equity compensation and capital structure.